{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:34:09Z","timestamp":1792020849010,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ccm.2025.12.006","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:39:34Z","timestamp":1770241174000},"page":"225-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Respiratory Viral and Bacterial Superinfection"],"prefix":"10.1016","volume":"47","author":[{"given":"Nima","family":"Naghshtabrizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keven M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccm.2025.12.006_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3201\/eid1408.071313","article-title":"Deaths from bacterial pneumonia during 1918-19 influenza pandemic","volume":"14","author":"Brundage","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3851\/IMP1730","article-title":"Preventing and treating secondary bacterial infections with antiviral agents","volume":"16","author":"McCullers","year":"2011","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/infdis\/jit190","article-title":"Bacterial complications of respiratory tract viral illness: a comprehensive evaluation","volume":"208","author":"Falsey","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.006_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijid.2023.04.003","article-title":"Determinants of poor clinical outcome in patients with influenza pneumonia: a systematic review and meta-analysis","volume":"131","author":"Arranz-Herrero","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ccm.2025.12.006_bib5","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04063","article-title":"The prevalence of influenza bacterial co-infection and its role in disease severity: a systematic review and meta-analysis","volume":"13","author":"Qiao","year":"2023","journal-title":"J Glob Health"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/ice.2021.96","article-title":"Bacterial coinfection in influenza pneumonia: rates, pathogens, and outcomes","volume":"43","author":"Bartley","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib7","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ccm.2025.12.006_bib8","article-title":"Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Che","year":"2023","journal-title":"PeerJ"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/irv.12971","article-title":"Respiratory syncytial virus-associated acute respiratory illness in adult non-immunocompromised patients: outcomes, determinants of outcomes, and the effect of oral ribavirin treatment","volume":"16","author":"Wongsurakiat","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib11","article-title":"Bacterial coinfection and superinfection in respiratory syncytial virus-associated acute respiratory illness: prevalence, pathogens, initial antibiotic-prescribing patterns and outcomes","volume":"8","author":"Wongsurakiat","year":"2023","journal-title":"Trop Med Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12030465","article-title":"The assessment of multiplex PCR in identifying bacterial infections in patients hospitalized with SARS-CoV-2 infection: a systematic review","volume":"12","author":"Bogdan","year":"2023","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/0882824041310577","article-title":"T cell responses to influenza virus infection: effector and memory cells","volume":"17","author":"Swain","year":"2004","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00107-18","article-title":"Host-pathogen interactions in gram-positive bacterial pneumonia","volume":"32","author":"Grousd","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1165\/rcmb.2007-0417OC","article-title":"Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae","volume":"42","author":"Pittet","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2021.1883965","article-title":"Airway tight junctions as targets of viral infections","volume":"9","author":"Linfield","year":"2021","journal-title":"Tissue Barriers"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/430954","article-title":"Influenza virus neuraminidase contributes to secondary bacterial pneumonia","volume":"192","author":"Peltola","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib19","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1038\/s41467-024-47963-5","article-title":"Airway epithelial CD47 plays a critical role in inducing influenza virus-mediated bacterial super-infection","volume":"15","author":"Moon","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03269-20","article-title":"GP96 drives exacerbation of secondary bacterial pneumonia following influenza A virus infection","volume":"12","author":"Sumitomo","year":"2021","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.ccm.2025.12.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111721","article-title":"The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial pneumonia","volume":"41","author":"Langou\u00ebt-Astri\u00e9","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1165\/rcmb.2014-0373OC","article-title":"Influenza-induced priming and leak of human lung microvascular endothelium upon exposure to Staphylococcus aureus","volume":"53","author":"Wang","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccm.2025.12.006_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fcimb.2020.00300","article-title":"Participation of the IL-10RB related cytokines, IL-22 and IFN-\u03bb in defense of the airway mucosal barrier","volume":"10","author":"Ahn","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chom.2012.05.017","article-title":"Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses","volume":"12","author":"Dela Cruz","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","article-title":"Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections","volume":"191","author":"Ghoneim","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib26","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.4049\/jimmunol.0902772","article-title":"Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung","volume":"184","author":"Small","year":"2010","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib27","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1128\/IAI.00789-06","article-title":"Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection","volume":"74","author":"McNamee","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.1701406","article-title":"Effects of influenza on alveolar macrophage viability are dependent on mouse genetic strain","volume":"201","author":"Califano","year":"2018","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.006_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-\u03b3 during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ccm.2025.12.006_bib30","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.4049\/jimmunol.1303049","article-title":"Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection","volume":"192","author":"Sun","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.20070891","article-title":"Sustained desensitization to bacterial toll-like receptor ligands after resolution of respiratory influenza infection","volume":"205","author":"Didierlaurent","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41385-018-0106-4","article-title":"CCR2 mediates increased susceptibility to post-H1N1 bacterial pneumonia by limiting dendritic cell induction of IL-17","volume":"12","author":"Gurczynski","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"9","key":"10.1016\/j.ccm.2025.12.006_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.15252\/embr.201540473","article-title":"TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection","volume":"16","author":"Ellis","year":"2015","journal-title":"EMBO Rep"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007360","article-title":"Alteration of Flt3-Ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection","volume":"14","author":"Beshara","year":"2018","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4049\/jimmunol.1002194","article-title":"Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice","volume":"186","author":"Kudva","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.006_bib36","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jit527","article-title":"Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production","volume":"209","author":"Robinson","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ajpath.2013.05.016","article-title":"Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses","volume":"183","author":"Damjanovic","year":"2013","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/mi.2017.32","article-title":"Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection","volume":"11","author":"Robinson","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajpath.2011.03.013","article-title":"Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis","volume":"179","author":"Narasaraju","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012449","article-title":"Deficient neutrophil responses early in influenza infection promote viral replication and pulmonary inflammation","volume":"21","author":"Gong","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ccm.2025.12.006_bib41","first-page":"56","article-title":"In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection","volume":"4","author":"Narayana","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2025.12.006_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1325269","article-title":"Impact of bronchoalveolar lavage from influenza A virus diseased pigs on neutrophil functions and growth of co-infecting pathogenic bacteria","volume":"15","author":"Lassnig","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2025.12.006_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001014","article-title":"PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology","volume":"6","author":"McAuley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"16","key":"10.1016\/j.ccm.2025.12.006_bib44","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1128\/JVI.01122-12","article-title":"Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential","volume":"86","author":"Varga","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/cei.13628","article-title":"Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia","volume":"205","author":"Peng","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib46","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/IAI.00298-15","article-title":"Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease","volume":"83","author":"Rynda-Apple","year":"2015","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.ccm.2025.12.006_bib47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI35412","article-title":"Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice","volume":"119","author":"Shahangian","year":"2009","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib48","doi-asserted-by":"crossref","first-page":"L158","DOI":"10.1152\/ajplung.00338.2014","article-title":"Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice","volume":"309","author":"Lee","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ccm.2025.12.006_bib49","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3389\/fimmu.2018.02589","article-title":"IFNAR2 is required for anti-influenza immunity and alters susceptibility to post-influenza bacterial superinfections. Original research","volume":"9","author":"Shepardson","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib50","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3818","article-title":"Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation","volume":"18","author":"Park","year":"2017","journal-title":"Nat Immunol"},{"issue":"39","key":"10.1016\/j.ccm.2025.12.006_bib51","doi-asserted-by":"crossref","first-page":"e9162","DOI":"10.1073\/pnas.1720930115","article-title":"Interferon stimulation creates chromatin marks and establishes transcriptional memory","volume":"115","author":"Kamada","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.006_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4049\/immunohorizons.1700030","article-title":"STAT1 is required for suppression of type 17 immunity during influenza and bacterial superinfection","volume":"1","author":"Lee","year":"2017","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.ccm.2025.12.006_bib53","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3389\/fimmu.2018.02151","article-title":"STAT2 signaling regulates macrophage phenotype during influenza and bacterial super-infection. Original research","volume":"9","author":"Gopal","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib54","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/mi.2016.49","article-title":"Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection","volume":"10","author":"Barthelemy","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.006_bib55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4049\/jimmunol.2100328","article-title":"IFN-\u03b3 drives TNF-\u03b1 hyperproduction and lethal lung inflammation during antibiotic treatment of postinfluenza Staphylococcus aureus pneumonia","volume":"207","author":"Verma","year":"2021","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009405","article-title":"Sequential targeting of interferon pathways for increased host resistance to bacterial superinfection during influenza","volume":"17","author":"Barman","year":"2021","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.ccm.2025.12.006_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012498","article-title":"Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection","volume":"20","author":"Antos","year":"2024","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib58","article-title":"Lambda interferon restructures the nasal microbiome and increases susceptibility to Staphylococcus aureus superinfection","volume":"7","author":"Planet Paul","year":"2016","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.006_bib59","article-title":"Interferon lambda inhibits bacterial uptake during influenza superinfection","volume":"87","author":"Rich Helen","year":"2019","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib60","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.4049\/jimmunol.172.12.7603","article-title":"IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection","volume":"172","author":"van der Sluijs","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-015-0168-8","article-title":"The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia","volume":"16","author":"Robinson","year":"2015","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.ccm.2025.12.006_bib62","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/eji.201444582","article-title":"Regulation of IFN-\u03b3 by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia","volume":"44","author":"Rynda-Apple","year":"2014","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib63","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.4049\/jimmunol.1301237","article-title":"Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1\u03b2 production in mice","volume":"191","author":"Robinson","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib64","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1128\/JVI.02943-12","article-title":"Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection","volume":"87","author":"Ivanov","year":"2013","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib65","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1128\/JVI.02456-10","article-title":"Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice","volume":"85","author":"Yageta","year":"2011","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib66","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.2400322","article-title":"Nrf2 regulates inflammation by modulating dendritic Cell\u2013T cell crosstalk during viral\u2013bacterial superinfection","volume":"213","author":"Duray","year":"2024","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib67","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4049\/jimmunol.2200261","article-title":"Heterotypic influenza infections mitigate susceptibility to secondary bacterial infection","volume":"209","author":"Cipolla","year":"2022","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2025.12.006_bib68","doi-asserted-by":"crossref","first-page":"e159422","DOI":"10.1172\/jci.insight.159422","article-title":"Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination","volume":"7","author":"Barman","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.ccm.2025.12.006_bib69","doi-asserted-by":"crossref","first-page":"e01667-24","DOI":"10.1128\/mbio.01667-24","article-title":"SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus","volume":"15","author":"Lubkin","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ccm.2025.12.006_bib70","doi-asserted-by":"crossref","first-page":"894534","DOI":"10.3389\/fimmu.2022.894534","article-title":"Time-dependent increase in susceptibility and severity of secondary bacterial infections during SARS-CoV-2. Original research","volume":"13","author":"Smith","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2025.12.006_bib71","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.2200198","article-title":"Coronavirus lung infection impairs host immunity against secondary bacterial infection by promoting lysosomal dysfunction","volume":"209","author":"Peng","year":"2022","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib72","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","article-title":"SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance","volume":"12","author":"Robinot","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ccm.2025.12.006_bib73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/vim.2011.0099","article-title":"SARS-CoV regulates immune function-related gene expression in human monocytic cells","volume":"25","author":"Hu","year":"2012","journal-title":"Viral Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2025.12.006_bib74","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12966","article-title":"The role of the lung microbiota and the gut\u2013lung axis in respiratory infectious diseases","volume":"20","author":"Dumas","year":"2018","journal-title":"Cell Microbiol"},{"issue":"6499","key":"10.1016\/j.ccm.2025.12.006_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ccm.2025.12.006_bib76","article-title":"IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections","author":"Kimmig","year":"2020","journal-title":"medRxiv [Preprint]"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/covid3020015","article-title":"Real-world safety and effectiveness of remdesivir and corticosteroids in hospitalized patients with COVID-19","volume":"3","author":"Caffrey","year":"2023","journal-title":"COVID"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib78","doi-asserted-by":"crossref","first-page":"e155055","DOI":"10.1172\/jci.insight.155055","article-title":"Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza","volume":"7","author":"Cambier","year":"2022","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.ccm.2025.12.006_bib79","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/jmm.0.47086-0","article-title":"Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein","volume":"56","author":"Avadhanula","year":"2007","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.006_bib80","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1203\/01.pdr.0000188699.55279.1b","article-title":"Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model","volume":"58","author":"Hament","year":"2005","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1164\/rccm.201311-2110OC","article-title":"Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection","volume":"190","author":"Smith","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib82","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1471-2164-14-378","article-title":"Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection","volume":"14","author":"Kimaro","year":"2013","journal-title":"BMC Genom"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.006_bib83","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000335548","article-title":"Respiratory syncytial virus persistence in macrophages downregulates intercellular adhesion Molecule-1 expression and reduces adhesion of non-typeable Haemophilus influenzae","volume":"55","author":"Arrevillaga","year":"2012","journal-title":"Intervirology"},{"issue":"3","key":"10.1016\/j.ccm.2025.12.006_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/0022-1317-49-3-227","article-title":"Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus","volume":"49","author":"Raza","year":"2000","journal-title":"J Med Microbiol"},{"issue":"10","key":"10.1016\/j.ccm.2025.12.006_bib85","first-page":"e00304","article-title":"RSV enhances Staphylococcus aureus bacterial growth in the lung","volume":"92","author":"Rich Helen","year":"2024","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ccm.2025.12.006_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32576-y","article-title":"Respiratory syncytial virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation","volume":"8","author":"Muraro","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ccm.2025.12.006_bib87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jmv.20631","article-title":"Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection","volume":"78","author":"Stark","year":"2006","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.ccm.2025.12.006_bib88","first-page":"121","article-title":"Community-acquired pneumonia: updated recommendations from the ATS and IDSA","volume":"102","author":"Armstrong","year":"2020","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.ccm.2025.12.006_bib89","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.ccm.2025.12.006_bib90","doi-asserted-by":"crossref","first-page":"e180986","DOI":"10.1172\/JCI180986","article-title":"Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia","volume":"134","author":"Sanches Santos Rizzo Zuttion","year":"2024","journal-title":"J Clin Investig"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312500108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312500108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:36:48Z","timestamp":1779997008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252312500108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S027252312500108X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.006","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Viral and Bacterial Superinfection","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}